2022年9月28日

2022年9月28日東部時間上午喂飼紐約——(業務線)——萬花筒,開拓一個操作係統,加快研究團隊表現,今天宣布完成6美元的種子資金,共同由蜂鳥公司和維度,從含咖啡因的資本,參與SV天使,Hawktail和個人投資者。的資金將用於投資於產品開發和團隊擴張,專注於軟件工程師。科學組織越來越多地采用跨學科團隊,從臨床醫生科學家工程師的長椅上。然而,有一個驚人的缺乏結構和清晰今天這種合作,使它很難正確追蹤科學決策。此外,不僅生成的數據量呈指數增加,但數據是經常換手。許多組織外包項目的各種組件,這意味著數據經常在個人之間共享,跨團隊,與外部合作夥伴,沒有統一的方式來理解什麼是誰幹的。萬花筒是一個基於雲計算的研究平台,作為“科學中心”,映射的位置數據,與它互動,以及為什麼。通過使用萬花筒跟蹤實驗之間的關係,公司可以做出更好的產品和管道的決定,速度更快。平台不斷研發團隊同步通過集中項目的鳥瞰圖和數據生成,並通過智能集成與其他軟件自動化的結果。這使科學家能夠讀取和寫入其他工具的技術堆棧,以直觀的方式,增強協作在每個階段的研究過程。 Researchers can now plan and track scientific work across both wet lab and computational teams, enabling more closed-loop systems to accelerate R&D. “The way people work in research is changing. Kaleidoscope bridges the gap between teams, on a platform that integrates with other software tools. The funding will enable us to deliver the best product and user experience to make research more collaborative, reproducible, and scalable,” said Bogdan Knezevic, Ph.D., CEO & Co-Founder, Kaleidoscope. “I’m thrilled to lead a team with co-founders Ahmed Elnaiem and David Yen to bring together diverse backgrounds across biology, engineering, and product design to build this foundational platform for the life sciences industry. We are building version control for science, to power tomorrow’s cures and scientific advances.” “The decentralization of data and work, and rise of computation has created a void where life science companies have resorted to spending hundreds of millions of dollars to build subpar internal tools that are not sustainable or scalable,” said Brandon White, Head of Product at Spring Discovery. “Data capture and meeting notes that sync with other applications have changed the way we work, but in life sciences there is a huge unmet need for more accessible cloud-based tools, so scientists can save time and make critical decisions faster to accelerate research. Kaleidoscope is a much-needed solution to this problem.” “Maintaining a single source of truth is critical in connecting and automating pipelines and workflows. Kaleidoscope is the connective tissue across wet lab and dry lab, integrating with the main tools of each arm to provide a holistic view of ongoing work,” said Pablo Lubroth, investor in Hummingbird Ventures. “There is an enormous amount of inefficiency and loss of productivity in manual data capture, disparate systems, and outdated tools. We’re extremely proud to support Kaleidoscope's next phase of growth to bring this much-needed solution to research teams.” “We launched Dimension as a dedicated firm at the convergence of tech and the life sciences. Industry is going through a drastic transformation. Discovery and clinical translation are no longer driven from siloed one-off experimentation but rather are compounding from accelerating gains in scale of data, reproducibility, and fidelity of experiment,” said Adam Goulburn, Founding Partner at Dimension. “The outcome here is an urgent and inevitable prioritization of large-scale cross-disciplinary research coordination, where data is no longer an afterthought. Kaleidoscope is addressing this need and building the operating system for modern scientific research. We are so thrilled to partner with the team here and are already seeing tremendous early engagement from the industry on this product.” About Kaleidoscope Kaleidoscope is a collaborative, cloud-based research platform designed for planning and tracking scientific work across wet lab and computational teams. By integrating with the modern research stack, we are changing the way research is conducted, with efficiency and transparency. Kaleidoscope is based in New York, NY. For more information, visit www.kaleidoscope.bio . Contacts